Amarantus BioSciences Releases New Video Interview with President and CEO Gerald Commissiong
Sunnyvale, CA, Jan. 6. 2012--Amarantus BioSciences Inc . (OTCBB: AMBS) is a biopharmaceutical company that has discovered a revolutionary therapeutic protein that could change the way many major diseases are treated. Recently, the biotech company released a video interview with its CEO, Gerald Commissiong that covers its development of MANF. Unlike Insmed Inc. (NASDAQ: INSM) or Alexion Pharmaceuticals Inc. (NASDAQ: ALXN), MANF works by reversing the